Podcast: America's Pharma Blame Game. Could Litigation Cripple GLP-1 Revolution?

By Cameron English and ChuckDinerstein — Jun 02, 2025

GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the manufacturers of these medicines now face a wave of lawsuits, with plaintiffs claiming they weren't warned about rare, but sometimes serious, side effects. Is this litigation driven by solid evidence, or are the tort lawyers out for yet another unearned payday? Let's take a look.

Image via Pixabay

Join Cameron English and Dr. Chuck Dinerstein on Episode 117 of the Science Dispatch podcast as they discuss:

The New Hunger Games: GLP Lawsuits

We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a growing swarm of lawsuits threatens to upend the billion-dollar industry. Are patients being blindsided, or is this just the next chapter in America's pharmaceutical blame game?

Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.

Tags:

Cameron English

Director of Bioscience

Cameron English is a writer, editor and co-host of the Science Facts and Fallacies Podcast. Before joining ACSH, he was managing editor at the Genetic Literacy Project.